VISCODERM pozycji w ofercie ALLPARA do użytku profesjonalnego, kupowanych bezpośrednio i z certyfikatem przy każdej wysyłce.
Viscoderm Skinkò
Viscoderm Skinkò is an injectable medical device, designed for deep revitalisation of the superficial and middle dermis. It is suitable for qualified practitioners treating the face and neck of healthy adult patients presenting early signs of ageing, superficial fine lines and dehydrated skin. The product combines non-reticulated hyaluronic acid of biotechnological origin with a buffered medium containing over 50 essential nutrients and is intended for professional use.
Najważniejsze zalety: Viscoderm Skinkò
- CE-marked Class III injectable medical device, CE 0123
- Non-reticulated hyaluronic acid of biotechnological origin, for high biocompatibility
- Buffered medium supplying over 50 essential nutrients, including vitamins, minerals and amino acids
- Improves the moisture levels of the facial epidermis
- Reduces the appearance of early-stage fine lines
- Normalises the skin's physiological environment and provides an antioxidant effect
- Restores the skin's natural glow and hydrodynamic balance
Wskazania i zastosowanie profesjonalne
Główne wskazania
- Early signs of ageing and superficial fine lines
- Dehydrated facial epidermis
- Loss of skin radiance and vitality
- Skin requiring deep revitalisation of the superficial and middle dermis
Zastosowanie profesjonalne
Viscoderm Skinkò is a Class III injectable medical device supplied for professional use only and is intended to be injected by a doctor experienced in the anatomy and physiology of the site to be treated. It is placed in the superficial or middle dermis of the face, with a 30G needle per injection area and separate needles for drawing up and injecting. Injection technique at the practitioner's discretion, following the manufacturer's current instructions. The protocol is three injection sessions at a maximum of every three weeks, not exceeding one 5 ml vial per session; touch-up sessions are needed to maintain the result. Apply only to healthy skin, and do not inject into the eyelids, glabella, eye circles or lips, nor into tendons, ligaments, bones, muscles or blood vessels.
Profil pacjenta
Viscoderm Skinkò is intended for healthy adult patients presenting early signs of ageing, superficial fine lines, a dehydrated facial epidermis or loss of skin radiance and vitality, and is indicated for the superficial and middle dermis of the face, including the peri-orbital, peribuccal, nasolabial folds and marionette lines. Suitability in any individual case is determined by the treating practitioner following clinical assessment. It must not be used in patients with known hypersensitivity or allergy to any of the components, in patients with a skin disease or skin alteration of any type, in patients with a history of auto-immune disease or receiving immunotherapy, in pregnant or breastfeeding women, or in people under 18 years of age. Patients with a history of streptococcal disease, such as recurrent angina or acute articular rheumatism, must undergo a double test before any injection, and injection is not recommended in acute articular rheumatism with cardiac involvement.
Jak działa Viscoderm Skinkò
Viscoderm Skinkò works through non-reticulated hyaluronic acid of biotechnological origin, delivered in a buffered medium that carries over 50 essential nutrients including vitamins, minerals and amino acids. Injected into the superficial and middle dermis, the hyaluronic acid restores hydrodynamic balance while the nutrient complex normalises the skin's physiological environment and provides an antioxidant effect. This makes it suitable for early ageing and superficial fine lines, where the treatment goal is revitalisation and radiance rather than volume.
Dlaczego warto zamawiać w Allpara
Allpara oferuje oryginalne, sprawdzone produkty VISCODERM od zweryfikowanych dostawców, z pełną identyfikowalnością partii i wsparciem ekspertów. Obsługujemy kliniki i specjalistów medycyny estetycznej, oferując produkty z oznakowaniem CE, szybką dostawę na terenie całej UE z naszego magazynu w UE oraz konkurencyjne ceny hurtowe. Najważniejsze są dla nas bezpieczeństwo, satysfakcja i efekty Twoich pacjentów - z indywidualnym wsparciem posprzedażowym dla Twojego spokoju.
Najczęściej zadawane pytania
How does Viscoderm Skinkò differ from Viscoderm Skinkò E?
Viscoderm Skinkò contains 2 mg of hyaluronic acid with the anti-ageing complex and targets early signs of ageing, superficial fine lines and dehydration. Viscoderm Skinkò E is the enriched version with 32 mg of hyaluronic acid, formulated for established wrinkles and loss of skin density.
Which nutrients does Viscoderm Skinkò supply?
Viscoderm Skinkò is supplied in a buffered medium containing over 50 essential nutrients, including vitamins, minerals and amino acids, alongside the hyaluronic acid.
Is the hyaluronic acid in Viscoderm Skinkò cross-linked?
No. Viscoderm Skinkò uses non-reticulated, that is non-cross-linked, hyaluronic acid of biotechnological origin.
Więcej od IBSA
ALIAXIN pozycji w ofercie ALLPARA do użytku profesjonalnego, kupowanych bezpośrednio i z certyfikatem przy każdej wysyłce.
ALIAXIN Produkty
Zobacz wszystkie 6PROFHILO pozycji w ofercie ALLPARA do użytku profesjonalnego, kupowanych bezpośrednio i z certyfikatem przy każdej wysyłce.
PROFHILO Produkty
Zobacz wszystkie 8SINOVIAL pozycji w ofercie ALLPARA do użytku profesjonalnego, kupowanych bezpośrednio i z certyfikatem przy każdej wysyłce.
SINOVIAL Produkty
Zobacz wszystkie 4Alternatywy dla kliniki
Kontynuuj przeglądanie
Viscoderm Skinkò
Viscoderm Skinkò is an injectable medical device, designed for deep revitalisation of the superficial and middle dermis. It is suitable for qualified practitioners treating the face and neck of healthy adult patients presenting early signs of ageing, superficial fine lines and dehydrated skin. The product combines non-reticulated hyaluronic acid of biotechnological origin with a buffered medium containing over 50 essential nutrients and is intended for professional use.
Najważniejsze zalety: Viscoderm Skinkò
- CE-marked Class III injectable medical device, CE 0123
- Non-reticulated hyaluronic acid of biotechnological origin, for high biocompatibility
- Buffered medium supplying over 50 essential nutrients, including vitamins, minerals and amino acids
- Improves the moisture levels of the facial epidermis
- Reduces the appearance of early-stage fine lines
- Normalises the skin's physiological environment and provides an antioxidant effect
- Restores the skin's natural glow and hydrodynamic balance
Wskazania i zastosowanie profesjonalne
Główne wskazania
- Early signs of ageing and superficial fine lines
- Dehydrated facial epidermis
- Loss of skin radiance and vitality
- Skin requiring deep revitalisation of the superficial and middle dermis
Zastosowanie profesjonalne
Viscoderm Skinkò is a Class III injectable medical device supplied for professional use only and is intended to be injected by a doctor experienced in the anatomy and physiology of the site to be treated. It is placed in the superficial or middle dermis of the face, with a 30G needle per injection area and separate needles for drawing up and injecting. Injection technique at the practitioner's discretion, following the manufacturer's current instructions. The protocol is three injection sessions at a maximum of every three weeks, not exceeding one 5 ml vial per session; touch-up sessions are needed to maintain the result. Apply only to healthy skin, and do not inject into the eyelids, glabella, eye circles or lips, nor into tendons, ligaments, bones, muscles or blood vessels.
Profil pacjenta
Viscoderm Skinkò is intended for healthy adult patients presenting early signs of ageing, superficial fine lines, a dehydrated facial epidermis or loss of skin radiance and vitality, and is indicated for the superficial and middle dermis of the face, including the peri-orbital, peribuccal, nasolabial folds and marionette lines. Suitability in any individual case is determined by the treating practitioner following clinical assessment. It must not be used in patients with known hypersensitivity or allergy to any of the components, in patients with a skin disease or skin alteration of any type, in patients with a history of auto-immune disease or receiving immunotherapy, in pregnant or breastfeeding women, or in people under 18 years of age. Patients with a history of streptococcal disease, such as recurrent angina or acute articular rheumatism, must undergo a double test before any injection, and injection is not recommended in acute articular rheumatism with cardiac involvement.
Jak działa Viscoderm Skinkò
Viscoderm Skinkò works through non-reticulated hyaluronic acid of biotechnological origin, delivered in a buffered medium that carries over 50 essential nutrients including vitamins, minerals and amino acids. Injected into the superficial and middle dermis, the hyaluronic acid restores hydrodynamic balance while the nutrient complex normalises the skin's physiological environment and provides an antioxidant effect. This makes it suitable for early ageing and superficial fine lines, where the treatment goal is revitalisation and radiance rather than volume.
Dlaczego warto zamawiać w Allpara
Allpara oferuje oryginalne, sprawdzone produkty VISCODERM z pełną identyfikowalnością partii, produktami z oznakowaniem CE, szybką dostawą na terenie całej UE i fachowym wsparciem posprzedażowym.
Najczęściej zadawane pytania
How does Viscoderm Skinkò differ from Viscoderm Skinkò E?
Viscoderm Skinkò contains 2 mg of hyaluronic acid with the anti-ageing complex and targets early signs of ageing, superficial fine lines and dehydration. Viscoderm Skinkò E is the enriched version with 32 mg of hyaluronic acid, formulated for established wrinkles and loss of skin density.
Which nutrients does Viscoderm Skinkò supply?
Viscoderm Skinkò is supplied in a buffered medium containing over 50 essential nutrients, including vitamins, minerals and amino acids, alongside the hyaluronic acid.
Is the hyaluronic acid in Viscoderm Skinkò cross-linked?
No. Viscoderm Skinkò uses non-reticulated, that is non-cross-linked, hyaluronic acid of biotechnological origin.